DSS-1. No financial disclosures

Similar documents
Corporate Medical Policy

Genetic diagnosis of limb girdle muscular dystrophy type 2A, A Case Report

Profile, types, duration and severity of muscular dystrophy: a clinical study at a tertiary care hospital

Gene therapy and genome editing technologies for the study and potential treatment of :

Learn the steps to identify pediatric muscle weakness and signs of neuromuscular disease.

1/28/2019. OSF HealthCare INI Care Center Team. Neuromuscular Disease: Muscular Dystrophy. OSF HealthCare INI Care Center Team: Who are we?

How to go around conducting a clinical trial in small populations: Duchenne muscular dystrophy

DMD Genetics: complicated, complex and critical to understand

This is a repository copy of A novel mutation in the FGD4 gene causing Charcot-Marie-Tooth disease..

GENETICS IN HEREDITARY NEUROPATHY

Cover Page. The handle holds various files of this Leiden University dissertation.

Muscular Dystrophies. Pinki Munot Consultant Paediatric Neurologist Great Ormond Street Hospital Practical Neurology Study days April 2018

A Tale of Five Demyelinating Neuropathies

Muscular Dystrophy. Biol 405 Molecular Medicine

419 Church Street East, Penrose, Auckland 1642 P O Box 12063, Penrose, Auckland

Increased Serum Creatine Kinase

Corporate Medical Policy

Charcot-Marie-Tooth disease (CMT) is the eponym

AII-type: Select the most appropriate answer

Toe-Walking. Benign Variant or Scourge of Bipedal Locomotion? Definition. Physical Exam. Absent Heel Strike 2/28/2011

Protocol. Genetic Testing for Duchenne and Becker Muscular Dystrophy

Neonatal Hypotonia. Encephalopathy acute No encephalopathy. Neurology Chapter of IAP

Genetic Testing for Neurologic Disorders

Charcot-Marie-Tooth Disease (CMT) Sometimes known as Hereditary Motor and Sensory neuropathy (HMSN) or Peroneal Muscular Atrophy (PMA)

MR Imaging of the Cauda Equina in Charcot-Marie-Tooth disease

Test Information Sheet

Stage I: Rule-Out Dashboard Secondary Findings in Adults

Pediatric Aspects of EDX

Corporate Medical Policy

Disorders of Muscle. Disorders of Muscle. Muscle Groups Involved in Myopathy. Needle Examination of EMG. History. Muscle Biopsy

Co-segregation of a homozygous SMN1 deletion and a heterozygous PMP22 duplication in a patient

Abstract. Introduction

Understanding genetics, mutation and other details. Stanley F. Nelson, MD 6/29/18

Peripheral Neuropathies

Evaluation of Peripheral Neuropathy. Evaluation of Peripheral Neuropathy - Introduction

Cavus Foot: Subtle and Not-So-Subtle AOFAS Resident Review Course September 28, 2013

Prosensa Corporate Overview Jefferies Healthcare Conference London, UK November 19, Hans Schikan, CEO

Deformity and Pain in Foot of Neuromuscular Disease

Exondys 51 (eteplirsen) injection Policy Number: Last Review: 10/2018 Origination: 10/2016 Next Review: 10/2019

Muscle Metabolism. Dr. Nabil Bashir

Guide to the use of nerve conduction studies (NCS) & electromyography (EMG) for non-neurologists

Approach to the Child with Developmental Delay

A family study of Charcot-Marie-Tooth disease

R J M E Romanian Journal of Morphology & Embryology

A Practical Approach to Polyneuropathy SLOCUM DICKSON ANNUAL TEACHING DAY NOVEMBER 4, 2017

A very simplified introduction to neuromuscular illnesses (NMIs) with a particular focus on the muscular dystrophies.

CAREGIVER PERCEPTIONS AND ADOLESCENT QUALITY OF LIFE IN DUCHENNE MUSCULAR DYSTROPHY. Julia Rae Stone. BS, University of California, Davis, CA, 2014

Muscular System. Disorders & Conditions

Clinical Policy Title: Genetic tests for Duchenne muscular dystrophy

Genetics, The Duchenne Registry and Your Family! Jen Ely, MS, CGC June 2, 2018

Genetics & CMT Q&A Questions from the CMTA Genetics & CMT Discussion Forum

Neuromuscular in the Pediatric Clinic: Recognition and Referral

Case Report Central Nervous System Demyelination in a Charcot-Marie-Tooth Type 1A Patient

Research Article Serum Creatinine Level: A Supplemental Index to Distinguish Duchenne Muscular Dystrophy from Becker Muscular Dystrophy

2- and 6-minute walk tests equally well assess walking capability in neuromuscular diseases

Paula Clemens NS-065/NCNP-01 Study Chair

Duchenne muscular dystrophy quantification of muscular parameters and prednisone therapy Beenakker, Ernesto Alexander Christiaan

Clinical Aspects of Peripheral Nerve and Muscle Disease. Roy Weller Clinical Neurosciences University of Southampton School of Medicine

A rare case of muscular dystrophy with POMT2 and FKRP gene mutation. Present by : Ghasem Khazaei Supervisor :Dr Mina Mohammadi Sarband

Accelerating Drug Discovery to Transform Patients Lives

CIDP + MMN - how to diagnose and treat. Dr Hadi Manji

TREAT-NMD Conference 2013

Clinical Policy: Eteplirsen Reference Number: NH.PHAR.288 Effective Date: 12/16

See Important Reminder at the end of this policy for important regulatory and legal information.

Critical Illness Polyneuropathy CIP and Critical Illness Myopathy CIM. Andrzej Sladkowski

Exercise induced cramps and myoglobinuria in dystrophinopathy a report of three Malaysian patients

Muscular System Module 3: Contraction and Relaxation *

Edasalonexent (CAT-1004) Program

Multifocal motor neuropathy: diagnostic criteria that predict the response to immunoglobulin treatment

Gait Disorders. Nicholas J. Silvestri, MD

Facts about Charcot-Marie-Tooth Disease

1GENERAL INFORMATION

DOWNLOAD OR READ : MYOPATHIES AND MUSCLE DISEASES HANDBOOK OF CLINICAL NEUROLOGY PDF EBOOK EPUB MOBI

NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE. Proposed Highly Specialised Technology Evaluation

Cover Page. The handle holds various files of this Leiden University dissertation.

Hypotonia Care Pathway Update: Diagnosis Garey Noritz, MD...

Case Report GNE Myopathy in Turkish Sisters with a Novel Homozygous Mutation

Motor and sensory nerve conduction studies

CHAPTER 6 2/9/2016. Learning Objectives List the four traits that all muscle types have in common.

International Journal of Health Sciences and Research ISSN:

Table of Contents. 1 Architecture of the peripheral nerve P. Young, M. Boentert

Movement Disorders. Psychology 372 Physiological Psychology. Background. Myasthenia Gravis. Many Types

Clinical features, particularly those of the central nervous system, of patients with Becker s muscular dystrophy, including autopsied cases

Cardiac Health in Duchenne: What we are Learning from Cardiac MRI

Corporate Medical Policy

ELECTROPHYSIOLOGICAL FEATURES OF INHERITED DEMYELINATING NEUROPATHIES: A REAPPRAISAL IN THE ERA OF MOLECULAR DIAGNOSIS

TREAT-NMD Care and Trial Sites Registry Information Chart

Imaging findings of Lower Extremity Peripheral Nerves in Charcot-Marie Tooth

Left peroneal neuropathy icd 10 code

X-Plain Muscles Reference Summary

Subject: Nerve Conduction Studies; F-Wave Studies; H- Reflex Studies

An Unusual Triad in Pediatric Neurology: A Case Report on Cerebral Palsy, Epilepsy, and Duchenne Muscular Dystrophy

Publications List. 1. General factsheets. 2. Medical conditions factsheets

Making sense of Nerve conduction & EMG

A CASE OF GIANT AXONAL NEUROPATHY HEMANANTH T SECOND YEAR POST GRADUATE IN PAEDIATRICS INSTITUTE OF SOCIAL PAEDIATRICS GOVERNMENT STANLEY HOSPITAL

Screening of dystrophin gene deletions in Egyptian patients with DMD/BMD muscular dystrophies

Pediatric Orthopedics: ``To Refer or Not to Refer``

SMA IS A SEVERE NEUROLOGICAL DISORDER [1]

III./10.4. Diagnosis. Introduction. A.) Laboratory tests. Laboratory tests, electrophysiology, muscle biopsy, genetic testing, imaging techniques

PLEO-CMT Top-line Results. Presentation October 16, 2018

Transcription:

DSS-1 No financial disclosures

Clinical History 9 year old boy with past medical history significant for cerebral palsy, in-turning right foot, left clubfoot that was surgically corrected at 3 years of age Able to crawl before surgery, able to walk afterwards, and ultimately walk independently His parents report a 6-month history of increasing weakness that is both proximal and distal on examination No family history of neuromuscular problems

Physical Examination Has difficulty rising from the floor and uses a Gowers-type maneuver by pulling up on a chair Shows a steppage gait that is slightly wide based Stretch reflexes absent Serum creatine kinase: 2800 IU/L Electromyography: Complex repetitive discharges

Work-up A left quadriceps muscle biopsy is performed

Slow myosin (type I fibers) Fast myosin (type II fibers)

Points for Discussion 1. Approach to diagnostic testing 2. Differential diagnosis

dystrophin antibodies c-terminus exon 50 exon 46 exons 7/8 utrophin nnos PATIENT control

Further Clinical History Nerve conduction studies are performed and show markedly prolonged distal motor latency and a conduction velocity of 7 m/sec (ref: 45-70 m/sec) in the right median nerve Right median sensory, right tibial motor, and right sural sensory responses are unrecordable Sural nerve biopsy is performed

Further Discussion 1. Approach to further diagnostic testing 2. Revised differential diagnosis

Diagnostic Considerations Elevated CK Proximal and distal weakness Loss of reflexes Markedly decreased nerve conduction velocity Presence of foot deformities

Diagnoses Dystrophinopathy most consistent with Duchenne muscular dystrophy DMD: duplication of exon 63 Charcot-Marie-Tooth disease type 1 PMP22: duplication of exons 1-5

Learning Objectives: DMD Types of mutations known to cause dystrophinopathies 95% of dystrophinopathy patients diagnosed with deletion/duplication analysis, followed by sequencing of coding exons and exon-intron boundaries Deletions usually worse than duplications phenotypically Muscle biopsy ultimately only necessary for patients with novel DMD variants of unknown significance, or mutations of deep intronic or regulatory regions Duplication of exon 63 is predicted to be out-of-frame, leading to early truncation of the transcript, transcript instability, and deficiency of dystrophin expression Juan-Mateu, et al. DMD Mutations in 576 Dystrophinopathy Families. PLoS One. 2015 Aug 18;10(8).

Learning Objectives: CMT Subtypes of CMT (1, 2, intermediate, 4, X-linked) determined by nerve conduction studies, family history, mode of inheritance CMT1: Numerous genetic subtypes Duplication of peripheral myelin protein 22 (PMP22; CMT 1A) and mutations in myelin protein zero (MPZ; CMT 1B) together account for 90% of cases Genetic testing historically started with these two genes with subsequent analysis of less common subtypes if no mutation initially identified Today: Increased availability of next generation sequencing from commercial labs offering multi-gene panels including PMP22 and MPZ with genes of less common subtypes

Markedly decreased nerve conduction velocity of 7 m/sec Schwann cell dystrophin (Dp116) starts with exon 56 DMD: Duplication of exon 63 Lancet Neurology 2:731-740, 2003

DMD combined with CMT Incidence in US (in the absence of a family history) DMD/BMD: 1/7200 CMT: 1/3300 Male patient: 1/24,000,000 chance of having both diseases

Double Trouble DMD/BMD + CMT Bergmann C, Senderek J, Hermanns B, Jauch A, Janssen B, Schröder JM, Karch D. Becker muscular dystrophy combined with X-linked Charcot-Marie-Tooth neuropathy. Muscle Nerve. 2000 May;23(5):818-23. CMT + muscular dystrophy Bütefisch CM, Lang DF, Gutmann L. The devastating combination of Charcot-Marie-Tooth disease and facioscapulohumeral muscular dystrophy. Muscle Nerve. 1998 Jun;21(6):788-91. DMD + other rare genetic diseases Donkervoort S, Schindler A, Tesi-Rocha C, Schreiber A, Leach ME, Dastgir J, Hu Y, Mankodi A, Wagner KR, Friedman NR, Bönnemann CG. 'Double trouble': diagnostic challenges in Duchenne muscular dystrophy in patients with an additional hereditary skeletal dysplasia. Neuromuscul Disord. 2013 Dec;23(12):955-61. doi: 10.1016/j.nmd.2013.08.003. Epub 2013 Aug 11.

Intramuscular nerve twig